SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-19-012420
Filing Date
2019-10-18
Accepted
2019-10-18 17:17:34
Documents
3
Period of Report
2019-10-15
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K a8k-vibativpub10x15x19.htm 8-K 38778
2 EXHIBIT 99.1 vibativpub10-15x19ex991.htm EX-99.1 27654
3 finalvibativdemonstra_image1.jpg GRAPHIC 37721
  Complete submission text file 0001628280-19-012420.txt   119528
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

IRS No.: 000000000
Type: 8-K | Act: 34 | File No.: 001-33637 | Film No.: 191158420
SIC: 2834 Pharmaceutical Preparations